Q&A | Next wave of immune-based therapies in R/R MM

Описание к видео Q&A | Next wave of immune-based therapies in R/R MM

This symposium closed with a panel Q&A session with live audience participation, where our panelists shared their perspectives on the next wave of immune-based therapies in relapsed/refractory multiple myeloma.

This independent educational activity was supported by Bristol Myers Squibb. All content was developed independently by the faculty.

Комментарии

Информация по комментариям в разработке